Congenital heart disease cyanotic
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Keri Shafer, M.D. [2], Atif Mohammad, M.D.; Kalsang Dolma, M.B.B.S.[3]
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief: Keri Shafer, M.D. [2]; Kalsang Dolma, M.B.B.S.[3]
Overview
A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries. Such defects include persistent truncus arteriosus, total anomalous pulmonary venous connection, tetralogy of Fallot, transposition of the great vessels, and tricuspid atresia.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Historical Perspective
Discovery
- There is limited information about the historical perspective of [disease name].
OR
- [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Famous Cases
The following are a few famous cases of [disease name]:
References
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief: Keri Shafer, M.D. [2]; Kalsang Dolma, M.B.B.S.[3]
Overview
Classification
Cyanotic heart defects, which account for approximately 25% of all congenital heart disease, include:[1][2][3][4]
- Tetralogy of Fallot (ToF)
- Total anomalous pulmonary venous connection
- Hypoplastic left heart syndrome (HLHS)
- Transposition of the great arteries (d-TGA)
- Truncus arteriosus (Persistent)
- Tricuspid atresia
- Interrupted aortic arch
- Coarctation of aorta
- Tricuspid atresia
- Pulmonary atresia (PA)
- Pulmonary stenosis (advanced)
References
- ↑ Engle MA (February 1976). “Cyanotic congenital heart disease”. Am. J. Cardiol. 37 (2): 283–308. doi:10.1016/0002-9149(76)90324-6. PMID 129000.
- ↑ Kothari, Shyam Sunder (1992). “Mechanism of cyanotic spells in tetralogy of Fallot — the missing link?”. International Journal of Cardiology. 37 (1): 1–5. doi:10.1016/0167-5273(92)90125-M. ISSN 0167-5273.
- ↑ Gathman GE, Nadas AS (July 1970). “Total anomalous pulmonary venous connection: clinical and physiologic observations of 75 pediatric patients”. Circulation. 42 (1): 143–54. doi:10.1161/01.cir.42.1.143. PMID 5425587.
- ↑ Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C (November 1994). “Presentation of obstructive left heart malformations in infancy”. Arch. Dis. Child. Fetal Neonatal Ed. 71 (3): F179–83. doi:10.1136/fn.71.3.f179. PMC 1061121. PMID 7820713.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Keri Shafer, M.D. [2], Atif Mohammad, M.D.; Kalsang Dolma, M.B.B.S.[3]
Overview
Pathophysiology
Tetrology of Fallot
- It is understood that tetralogy of fallot is the result of improper positioning of the outlet septum.[1][2][3]
- In the normal heart, the outlet septum is an indistinguishable component of the crista supraventricularis that communicates with the septomarginal trabeculae to divide the right and left ventricular cavities.
- In Tetralogy of Fallot, proper ventricular septation is perturbed by anterocephalad displacement of the outlet septum relative to the septomarginal trabecula.
- The direct consequence of this misalignment is an overriding aortic orifice and a ventricular septal defect, resulting in an intracardiac right to left shunt of blood.
- In addition, anterocephalad displacement of the outlet septum indirectly predisposes the pulmonary trunk to stenosis in the setting of septoparietal trabecular hypertrophy.
- Together, the displacement of the outlet septum coupled with the hypertrophic arrangement of the septoparietal trabeculae account for the three anatomical cardinal defects in Tetralogy of Fallot – aortic dextroposition, interventricular communication (VSD), and pulmonary stenosis.
- The fourth defect – right ventricular hypertrophy – is a hemodynamic consequence of these three morphologic changes, as the right ventricle physiologically adapts to the increased resistance of a stenotic pulmonary trunk.
Total Anomalous Pulmonary Venous Connection
- In this condition,the right side of heart is receiving blood both from pulmonary and systemic circulation.[4][5]
- There is a mixing of oxygenated pulmonary venous blood with deoxygenated blood from systemic circulation.
- The mixing of blood could occur at three levels i.e. supracardiac, infracardiac and cardiac.
- In the former two the mixing occurs outside the heart and in latter inside the heart (right atrium)
Transpostion of Great Arteries
- In the TGA the aorta arises from the morphologic right ventricle via a subaortic infundibulum and the pulmonary artery arises from the morphologic left ventricle, without a subpulmonary infundibulum.[6][7][8][9]
- These ventriculoarterial connection is known as ventriculoarterial discordance.
- As a consequence, there is a a fibrous continuity between the mitral and pulmonary valve, but no continuity between the tricuspid and aortic valve.
- The abnormal origin of the great arteries results in an altered spiral relationship.
- Therefore, the aorta and pulmonary artery run parallel to each other
- In normal heart thus the circulation is in series.
- However, in transposition of the great vessels circulation is in parallel
Truncus Arteriosus
- In truncus arteriosus, the pulmonary arteries are connected to the aorta.
- A decrease in PVR at birth causes a left to right shunt with evidence of congestive heart failure.
- These patients have a very high incidence of pulmonary hypertension and vascular disease.
Tricuspid Atresia
- In tricuspid atresia, there is no continuity between the right atrium and right ventricle. Blood from superior vena cava and inferior vena cava is forced across intra atrial connection into the left heart.
- As a consequence, oxygen saturation in the left atrial blood is diminished.
Hypoplastic Left Heart Syndrome
- In patients with hypoplastic left heart syndrome, the left side of the heart is unable to send enough blood to the body.
- As a result, the right side of the heart must maintain the circulation for both the lungs and the body.
- The right ventricle can support the circulation to both the lungs and the body for a while, but this extra workload eventually causes the right side of the heart to fail.
Genetics
- Genes involved in the pathogenesis of tetralogy of fallot include:[10][11][12][13][14][15][16]
- The cellular processes that underlie cardiogenesis are extensively regulated in the developing heart.
- Proper cardiac development requires the complex orchestration of cardiac transcription factors and signaling pathways in a spatiotemporal specific manner.
- Previous genetic studies demonstrated that mutations in numerous genes encoding cardiac transcription factors and cell signaling proteins have a role in the development of Tetralogy of Fallot.
- Specifically, heterozygous mutations in NKX2-5, HAND1, TBX5, and GATA4 have been reported in familial forms of disease.
- Many of these single gene mutations result in haploinsufficiency and suggest a dose dependent relationship between genetic expression and disease.
- While the mechanistic basis of this relationship is currently poorly understood, it is hypothesized that disruption of the direct protein–protein interactions that allow these transcription factors to work synergistically impedes the activation of downstream targets and signaling pathways central to cardiac morphogenesis.
- In addition, recent whole-exome sequencing investigations have introduced a novel role for epigenetic dysregulation in the pathogenesis of Tetralogy of Fallot.
- Aberrant epigenetic modifications are thought to provide an alternative mechanism to perturb normal spatiotemporal expression of these essential developmental genes.
Associated Conditions
- Conditions associated with tetralogy of fallot include:[19][20][21][22]
- Left superior vena cava
- Anomalies of the mitral valve
- Anomalies of the tricuspid valve
- Stenosis of the left pulmonary artery, in 40% of patients
- A bicuspid pulmonary valve, in 40% of patients
- Right sided aortic arch, in 25% of patients
- Coronary artery anomalies, in 10% of patients
- An atrial septal defect, in which case the syndrome is sometimes called a pentalogy of Fallot.
- An atrioventricular septal defect
- Partially or totally anomalous pulmonary venous return
- Forked ribs and scoliosis
- Associated abnormalities include cleft lip, cleft palate, hypospadias, skeletal and craniofacial abnormalities.
- Conditions associated with total anomalous pulmonary venous connection
- Conditions associated with TGA include:
- Ventricular septal defect
- Pulmonary stenosis
- Left atrioventricular valve regurgitation (tricuspid or systemic)
- Complete heart block
- Conditions associated with truncus arteriosus include:
- DiGeorge syndrome
Gross Pathology
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ Anderson RH, Jacobs ML (2008). “The anatomy of tetralogy of Fallot with pulmonary stenosis”. Cardiol Young. 18 Suppl 3: 12–21. doi:10.1017/S1047951108003259. PMID 19094375.
- ↑ Bashore TM (2007). “Adult congenital heart disease: right ventricular outflow tract lesions”. Circulation. 115 (14): 1933–47. doi:10.1161/CIRCULATIONAHA.105.592345. PMID 17420363.
- ↑ Bailliard F, Anderson RH (2009). “Tetralogy of Fallot”. Orphanet J Rare Dis. 4: 2. doi:10.1186/1750-1172-4-2. PMC 2651859. PMID 19144126.
- ↑ NEILL CA (December 1956). “Development of the pulmonary veins; with reference to the embryology of anomalies of pulmonary venous return”. Pediatrics. 18 (6): 880–7. PMID 13378917.
- ↑ CRAIG JM, DARLING RC, ROTHNEY WB (1957). “Total pulmonary venous drainage into the right side of the heart; report of 17 autopsied cases not associated with other major cardiovascular anomalies”. Lab. Invest. 6 (1): 44–64. PMID 13386206.
- ↑ Warnes CA (December 2006). “Transposition of the great arteries”. Circulation. 114 (24): 2699–709. doi:10.1161/CIRCULATIONAHA.105.592352. PMID 17159076.
- ↑ Levin, Daniel L. (1977). “d-Transposition of the Great Vessels in the Neonate”. Archives of Internal Medicine. 137 (10): 1421. doi:10.1001/archinte.1977.03630220061015. ISSN 0003-9926.
- ↑ Rashkind, William J. (1966). “Creation of an Atrial Septal Defect Without Thoracotomy”. JAMA. 196 (11): 991. doi:10.1001/jama.1966.03100240125026. ISSN 0098-7484.
- ↑ Hornung TS, Bernard EJ, Celermajer DS, Jaeggi E, Howman-Giles RB, Chard RB, Hawker RE (November 1999). “Right ventricular dysfunction in congenitally corrected transposition of the great arteries”. Am. J. Cardiol. 84 (9): 1116–9, A10. doi:10.1016/s0002-9149(99)00516-0. PMID 10569681.
- ↑ Olson EN (2006). “Gene regulatory networks in the evolution and development of the heart”. Science. 313 (5795): 1922–7. doi:10.1126/science.1132292. PMID 17008524.
- ↑ Yang YQ, Gharibeh L, Li RG, Xin YF, Wang J, Liu ZM; et al. (2013). “GATA4 loss-of-function mutations underlie familial tetralogy of fallot”. Hum Mutat. 34 (12): 1662–71. doi:10.1002/humu.22434. PMID 24000169.
- ↑ Bruneau BG (2008). “The developmental genetics of congenital heart disease”. Nature. 451 (7181): 943–8. doi:10.1038/nature06801. PMID 18288184.
- ↑ Bruneau BG, Srivastava D (2014). “Congenital heart disease: entering a new era of human genetics”. Circ Res. 114 (4): 598–9. doi:10.1161/CIRCRESAHA.113.303060. PMID 24526674.
- ↑ Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R; et al. (2001). “Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation”. Nat Genet. 28 (3): 276–80. doi:10.1038/90123. PMID 11431700.
- ↑ Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA; et al. (2003). “GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5”. Nature. 424 (6947): 443–7. doi:10.1038/nature01827. PMID 12845333.
- ↑ Sheng W, Qian Y, Wang H, Ma X, Zhang P, Diao L; et al. (2013). “DNA methylation status of NKX2-5, GATA4 and HAND1 in patients with tetralogy of fallot”. BMC Med Genomics. 6: 46. doi:10.1186/1755-8794-6-46. PMC 3819647. PMID 24182332.
- ↑ Phelan, K.; McDermid, H.E. (2011). “The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)”. Molecular Syndromology. doi:10.1159/000334260. ISSN 1661-8777.
- ↑ Bleyl, Steven B.; Saijoh, Yukio; Bax, Noortje A.M.; Gittenberger-de Groot, Adriana C.; Wisse, Lambertus J.; Chapman, Susan C.; Hunter, Jennifer; Shiratori, Hidetaka; Hamada, Hiroshi; Yamada, Shigehito; Shiota, Kohei; Klewer, Scott E.; Leppert, Mark F.; Schoenwolf, Gary C. (2010). “Dysregulation of the PDGFRA gene causes inflow tract anomalies including TAPVR: integrating evidence from human genetics and model organisms”. Human Molecular Genetics. 19 (7): 1286–1301. doi:10.1093/hmg/ddq005. ISSN 0964-6906.
- ↑ Dabizzi RP, Caprioli G, Aiazzi L, Castelli C, Baldrighi G, Parenzan L, Baldrighi V (January 1980). “Distribution and anomalies of coronary arteries in tetralogy of fallot”. Circulation. 61 (1): 95–102. doi:10.1161/01.cir.61.1.95. PMID 7349946.
- ↑ Satyanarayana Rao, B.N.; Anderson, Ray C.; Edwards, Jesse E. (1971). “Anatomic variations in the tetralogy of Fallot”. American Heart Journal. 81 (3): 361–371. doi:10.1016/0002-8703(71)90106-2. ISSN 0002-8703.
- ↑ Muster, Alexander J.; Paul, Milton H.; Nikaidoh, Hisashi (1973). “Tetralogy of Fallot Associated with Total Anomalous Pulmonary Venous Drainage”. Chest. 64 (3): 323–326. doi:10.1378/chest.64.3.323. ISSN 0012-3692.
- ↑ Saifi, Comron; Matsumoto, Hiroko; Vitale, Michael G.; Roye, David P.; Hyman, Joshua E. (2012). “The incidence of congenital scoliosis in infants with tetralogy of Fallot based on chest radiographs”. Journal of Pediatric Orthopaedics B. 21 (4): 313–316. doi:10.1097/BPB.0b013e3283536872. ISSN 1060-152X.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor(s)-In-Chief: Keri Shafer, M.D. [2], Atif Mohammad, M.D.
Overview
Causes
Causes in Alphabetical Order
- Aortic valve is unable to open wide enough.
- Chemical exposure
- Coarctation or complete interruption of the aorta
- Ebstein’s anomaly
- Genetic and chromosomal syndromes, such as:
- Hypoplastic left heart syndrome
- Infections (such as rubella) during pregnancy
- Medications prescribed by your doctor or bought on your own and used during pregnancy
- Poorly controlled blood sugar levels in women who have diabetes during pregnancy
- Pulmonary valve may be absent or unable to open wide enough.
- Street drugs used during pregnancy
- Tetralogy of Fallot
- Total anomalous pulmonary venous connection
- Transposition of the great arteries
- Tricuspid valve may be absent or unable to open wide enough.
- Truncus arteriosus
References
Differentiating Cyanotic heart defect from other Diseases

For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.,Eiman Ghaffarpasand, M.D. [2],Kalsang Dolma, M.B.B.S.[3]
Overview
Differentiating Cyanotic Heart Defect from other Diseases
- Respiratory Causes: The hyperoxia test is useful in distinguishing cardiac from pulmonary causes of cyanosis in the neonate
References
- ↑ Cherry, James D. (2008). “Croup”. New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
- ↑ Abdallah C (2012). “Acute epiglottitis: Trends, diagnosis and management”. Saudi J Anaesth. 6 (3): 279–81. doi:10.4103/1658-354X.101222. PMC 3498669. PMID 23162404.
- ↑ Qureshi A, Behzadi A (2008). “Foreign-body aspiration in an adult”. Can J Surg. 51 (3): E69–70. PMC 2496600. PMID 18682760.
- ↑ Liston SL, Gehrz RC, Siegel LG, Tilelli J (August 1983). “Bacterial tracheitis”. Am. J. Dis. Child. 137 (8): 764–7. PMID 6869336.
- ↑ Spicuzza L, Caruso D, Di Maria G (2015). “Obstructive sleep apnoea syndrome and its management”. Ther Adv Chronic Dis. 6 (5): 273–85. doi:10.1177/2040622315590318. PMC 4549693. PMID 26336596.
- ↑ Kim V, Criner GJ (2013). “Chronic bronchitis and chronic obstructive pulmonary disease”. Am J Respir Crit Care Med. 187 (3): 228–37. doi:10.1164/rccm.201210-1843CI. PMC 4951627. PMID 23204254.
- ↑ Peroni DG, Boner AL (September 2000). “Atelectasis: mechanisms, diagnosis and management”. Paediatr Respir Rev. 1 (3): 274–8. doi:10.1053/prrv.2000.0059. PMID 12531090.
- ↑ Lee JS, Im JG, Ahn JM, Kim YM, Han MC (August 1992). “Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT”. Radiology. 184 (2): 451–4. doi:10.1148/radiology.184.2.1620846. PMID 1620846.
- ↑ Simonetti AF, Viasus D, Garcia-Vidal C, Carratalà J (2014). “Management of community-acquired pneumonia in older adults”. Ther Adv Infect Dis. 2 (1): 3–16. doi:10.1177/2049936113518041. PMC 4072047. PMID 25165554.
- ↑ Litonjua AA (June 2009). “Childhood asthma may be a consequence of vitamin D deficiency”. Curr Opin Allergy Clin Immunol. 9 (3): 202–7. doi:10.1097/ACI.0b013e32832b36cd. PMID 19365260.
- ↑ “Cystic fibrosis – Genetics Home Reference”.
- ↑ Qureshi H, Sharafkhaneh A, Hanania NA (2014). “Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications”. Ther Adv Chronic Dis. 5 (5): 212–27. doi:10.1177/2040622314532862. PMC 4131503. PMID 25177479.
- ↑ Olalekan, Adebimpe Wasiu; Oluwaseun, Faremi Ayodeji; Oladele, Hassan Abdul-Wasiu; Akeem, Adeyemi Damilare (2015). “Evaluation of electrolyte imbalance among tuberculosis patients receiving treatments in Southwestern Nigeria”. Alexandria Journal of Medicine. 51 (3): 255–260. doi:10.1016/j.ajme.2014.10.003. ISSN 2090-5068.
- ↑ Shaw J, Marshall T, Morris H, Hayton C, Chaudhuri N (2017). “Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age”. J Thorac Dis. 9 (11): 4700–4707. doi:10.21037/jtd.2017.10.111. PMC 5721024. PMID 29268540.
- ↑ Yen CM, Lin CL, Lin MC, Chen HY, Lu NH, Kao CH (2016). “Pneumoconiosis increases the risk of congestive heart failure: A nationwide population-based cohort study”. Medicine (Baltimore). 95 (25): e3972. doi:10.1097/MD.0000000000003972. PMC 4998335. PMID 27336897.
- ↑ Hartwig MG, D’Amico TA (June 2010). “Thoracoscopic lobectomy: the gold standard for early-stage lung cancer?”. Ann. Thorac. Surg. 89 (6): S2098–101. doi:10.1016/j.athoracsur.2010.02.102. PMID 20493989.
- ↑ Ochiai R (2015). “Mechanical ventilation of acute respiratory distress syndrome”. J Intensive Care. 3 (1): 25. doi:10.1186/s40560-015-0091-6. PMC 4456061. PMID 26045965.
- ↑ Bĕlohlávek J, Dytrych V, Linhart A (2013). “Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism”. Exp Clin Cardiol. 18 (2): 129–38. PMC 3718593. PMID 23940438.
- ↑ Khurshid I, Downie GH (2002). “Pulmonary arteriovenous malformation”. Postgrad Med J. 78 (918): 191–7. PMC 1742331. PMID 11930021.
- ↑ Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). “Massive spontaneous hemothorax during the immediate postpartum period”. Tex Heart Inst J. 36 (3): 247–9. PMC 2696501. PMID 19568398.
- ↑ Chanatry BJ (1992). “Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy”. Anesth. Analg. 74 (4): 613–5. PMID 1554132.
- ↑ Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S (2017). “Pulmonary Hypertension”. Dtsch Arztebl Int. 114 (5): 73–84. doi:10.3238/arztebl.2017.0073. PMC 5331483. PMID 28241922.
- ↑ Pettiford BL, Luketich JD, Landreneau RJ (February 2007). “The management of flail chest”. Thorac Surg Clin. 17 (1): 25–33. doi:10.1016/j.thorsurg.2007.02.005. PMID 17650694.
- ↑ Luh SP (2010). “Review: Diagnosis and treatment of primary spontaneous pneumothorax”. J Zhejiang Univ Sci B. 11 (10): 735–44. doi:10.1631/jzus.B1000131. PMC 2950234. PMID 20872980.
- ↑ Macris MP, Ott DA, Cooley DA (1992). “Complete atrioventricular canal defect: surgical considerations”. Tex Heart Inst J. 19 (3): 239–43. PMC 326195. PMID 15227445.
- ↑ Safi LM, Liberthson RR, Bhatt A (September 2016). “Current Management of Ebstein’s Anomaly in the Adult”. Curr Treat Options Cardiovasc Med. 18 (9): 56. doi:10.1007/s11936-016-0478-2. PMID 27439413.
- ↑ Bailliard F, Anderson RH (2009). “Tetralogy of Fallot”. Orphanet J Rare Dis. 4: 2. doi:10.1186/1750-1172-4-2. PMC 2651859. PMID 19144126.
- ↑ Yoo BW, Park HK (2013). “Pulmonary stenosis and pulmonary regurgitation: both ends of the spectrum in residual hemodynamic impairment after tetralogy of Fallot repair”. Korean J Pediatr. 56 (6): 235–41. doi:10.3345/kjp.2013.56.6.235. PMC 3693041. PMID 23807889.
- ↑ Stein P (March 2007). “Total anomalous pulmonary venous connection”. AORN J. 85 (3): 509–20, quiz 521–4. doi:10.1016/S0001-2092(07)60123-9. PMID 17352891.
- ↑ Martins P, Castela E (2008). “Transposition of the great arteries”. Orphanet J Rare Dis. 3: 27. doi:10.1186/1750-1172-3-27. PMC 2577629. PMID 18851735.
- ↑ Van Praagh R (1987). “Truncus arteriosus: what is it really and how should it be classified?”. Eur J Cardiothorac Surg. 1 (2): 65–70. PMID 2856609.
- ↑ “Patent Ductus Arteriosus – National Library of Medicine – PubMed Health”.
- ↑ Inamdar AA, Inamdar AC (2016). “Heart Failure: Diagnosis, Management and Utilization”. J Clin Med. 5 (7). doi:10.3390/jcm5070062. PMC 4961993. PMID 27367736.
- ↑ Maganti K, Rigolin VH, Sarano ME, Bonow RO (2010). “Valvular heart disease: diagnosis and management”. Mayo Clin Proc. 85 (5): 483–500. doi:10.4065/mcp.2009.0706. PMC 2861980. PMID 20435842.
- ↑ “Myocardial Infarction (Heart Attack): Symptoms – National Library of Medicine – PubMed Health”.
- ↑ Werdan K, Ruß M, Buerke M, Delle-Karth G, Geppert A, Schöndube FA; et al. (2012). “Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline”. Dtsch Arztebl Int. 109 (19): 343–51. doi:10.3238/arztebl.2012.0343. PMC 3364528. PMID 22675405.
- ↑ Marian AJ, Braunwald E (September 2017). “Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy”. Circ. Res. 121 (7): 749–770. doi:10.1161/CIRCRESAHA.117.311059. PMID 28912181.
- ↑ Hoffmeier A, Sindermann JR, Scheld HH, Martens S (2014). “Cardiac tumors–diagnosis and surgical treatment”. Dtsch Arztebl Int. 111 (12): 205–11. doi:10.3238/arztebl.2014.0205. PMC 3983698. PMID 24717305.
- ↑ Kannan M, Vijayanand G (2010). “Mitral stenosis and pregnancy: Current concepts in anaesthetic practice”. Indian J Anaesth. 54 (5): 439–44. doi:10.4103/0019-5049.71043. PMC 2991654. PMID 21189882.
- ↑ Das S, Maiti A (2013). “Acrocyanosis: an overview”. Indian J Dermatol. 58 (6): 417–20. doi:10.4103/0019-5154.119946. PMC 3827510. PMID 24249890.
- ↑ Lyaker MR, Tulman DB, Dimitrova GT, Pin RH, Papadimos TJ (2013). “Arterial embolism”. Int J Crit Illn Inj Sci. 3 (1): 77–87. doi:10.4103/2229-5151.109429. PMC 3665125. PMID 23724391.
- ↑ Block JA, Sequeira W (June 2001). “Raynaud’s phenomenon”. Lancet. 357 (9273): 2042–8. doi:10.1016/S0140-6736(00)05118-7. PMID 11438158.
- ↑ Cohen R, Mena D, Carbajal-Mendoza R, Matos N, Karki N (2008). “Superior vena cava syndrome: A medical emergency?”. Int J Angiol. 17 (1): 43–6. PMC 2728369. PMID 22477372.
- ↑ Fan CM (2005). “Venous pathophysiology”. Semin Intervent Radiol. 22 (3): 157–61. doi:10.1055/s-2005-921949. PMC 3036287. PMID 21326688.
- ↑ Ashurst J, Wasson M (July 2011). “Methemoglobinemia: a systematic review of the pathophysiology, detection, and treatment”. Del Med J. 83 (7): 203–8. PMID 21954509.
- ↑ Spivak JL (February 2002). “The optimal management of polycythaemia vera”. Br. J. Haematol. 116 (2): 243–54. PMID 11841424.
- ↑ Goldman RD (2015). “Breath-holding spells in infants”. Can Fam Physician. 61 (2): 149–50. PMC 4325862. PMID 25676645.
- ↑ Goldenberg MM (2010). “Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment”. P T. 35 (7): 392–415. PMC 2912003. PMID 20689626.
- ↑ Brown EN, Lydic R, Schiff ND (2010). “General anesthesia, sleep, and coma”. N Engl J Med. 363 (27): 2638–50. doi:10.1056/NEJMra0808281. PMC 3162622. PMID 21190458.
- ↑ McAllister TW (2011). “Neurobiological consequences of traumatic brain injury”. Dialogues Clin Neurosci. 13 (3): 287–300. PMC 3182015. PMID 22033563.
- ↑ Parati G, Agostoni P, Basnyat B, Bilo G, Brugger H, Coca A, Festi L, Giardini G, Lironcurti A, Luks AM, Maggiorini M, Modesti PA, Swenson ER, Williams B, Bärtsch P, Torlasco C (January 2018). “Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions”. Eur. Heart J. doi:10.1093/eurheartj/ehx720. PMID 29340578.
- ↑ Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL (2016). “Sepsis and septic shock”. Nat Rev Dis Primers. 2: 16045. doi:10.1038/nrdp.2016.45. PMC 5538252. PMID 28117397.
- ↑ Rehberg S, Maybauer MO, Enkhbaatar P, Maybauer DM, Yamamoto Y, Traber DL (2009). “Pathophysiology, management and treatment of smoke inhalation injury”. Expert Rev Respir Med. 3 (3): 283–297. doi:10.1586/ERS.09.21. PMC 2722076. PMID 20161170.
- ↑ Marriott, Bernadette (1996). Nutritional needs in cold and in high-altitude environments : applications for military personnel in field operations. Washington, D.C: National Academy Press. ISBN 0-309-05484-2.
Epidemiology and Demographics
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Overview
Epidemiology and Demographics
Cyanotic heart disease account for approximately 15 percent of all CHD cases and one-third of potentially fatal forms of congenital heart disease.[1]
References
- ↑ Wren C, Reinhardt Z, Khawaja K (2008). “Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations”. Arch Dis Child Fetal Neonatal Ed. 93 (1): F33–5. doi:10.1136/adc.2007.119032. PMID 17556383.
Risk Factors
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Risk Factors
- Chemical exposure
- Genetic and chromosomal syndromes, such as Down syndrome, trisomy 13, Turner syndrome, Marfan syndrome, Noonan syndrome, and Ellis-van Creveld syndrome
- Infections (such as rubella) during pregnancy
- Poorly controlled blood sugar levels in women who have diabetes during pregnancy
- Some prescription and over-the-counter medications and street drugs used during pregnancy
References
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]
References
Natural History, Complications and Prognosis
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Keri Shafer, M.D. [2], Atif Mohammad, M.D.; Kalsang Dolma, M.B.B.S.[3]
Overview
Natural History
Complications
The outlook depends on the specific disorder.
Complications of cyanotic heart disease include:
- Abnormal heart rhythms and sudden death
- Chronic high blood pressure in the blood vessels of the lung
- Heart failure
- Infection in the heart
- Stroke
- Brain Abscess
- Thrombosis/Hemorrhage
- Renal problems/gout
- Scoliosis: 3 times more common in these patients
- Gallstones: Due to increased RBC turnover
Prognosis
References
Diagnosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings| | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | CT | MRI | Other Imaging Findings | Other Imaging Findings| Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Interventions| Surgery | Primary Prevention | Secondary Prevention| Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
